FRI112 HS135, A Novel Activin And GDF Trap With Dual Cardiopulmonary And Metabolic Mode Of Action, Is Efficacious In An Obesogenic Model Of Heart Failure

Disclosure: G. Schang: Employee; Self; 35Pharma Inc. M. Poujol de Molliens: Employee; Self; 35Pharma Inc. E. Brûlé: Employee; Self; 35Pharma Inc. C. Chauvet: Employee; Self; 35Pharma Inc. J. Denis: Employee; Self; 35Pharma Inc. A. Sours: Employee; Self; 35Pharma Inc. V. Ganesh: Employee; Self; 35Pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Schang, Gauthier, de Molliens, Mathilde Poujol, Brûlé, Emilie, Chauvet, Cristina, Denis, Jean-François, Sours, Ariane, Ganesh, Vannakambadi, Tremblay, Gilles, Schoelermann, Julia, O'Connor-McCourt, Maureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553462/
http://dx.doi.org/10.1210/jendso/bvad114.625

Ejemplares similares

Ejemplares similares